Ozempic works by mimicking a natural gut hormone called GLP-1, which your body releases after eating. The drug’s active ingredient, semaglutide, binds to the same receptors as this hormone but stays active in your body far longer, producing stronger effects on blood sugar, appetite, and digestion. The result is a medication that works on multiple systems at once to lower blood sugar and reduce food intake.
The Hormone Ozempic Imitates
Every time you eat, your gut releases GLP-1 (glucagon-like peptide-1). This hormone signals your pancreas to produce insulin, tells your liver to stop dumping extra sugar into your bloodstream, and communicates with your brain that you’ve had enough food. It’s a built-in system for managing energy after meals.
The problem is that natural GLP-1 breaks down in minutes. An enzyme called DPP-4 chews it up almost immediately, so its effects are brief. In people with type 2 diabetes, this system often isn’t working well to begin with, meaning even that short burst of GLP-1 activity may not be enough to keep blood sugar in check.
Semaglutide is engineered to survive where natural GLP-1 cannot. It shares 94% of its structure with the human hormone, but two key amino acid substitutions make all the difference. One of those changes, at position 8 in the amino acid chain, makes semaglutide resistant to that DPP-4 enzyme. The drug also has a fatty acid chain attached that lets it bind to a protein in your blood called albumin, which acts like a slow-release carrier. The result: semaglutide has a half-life of about one week and stays in your circulation for roughly five weeks after a single dose. That’s why you only inject it once a week.
What Happens in Your Pancreas
When semaglutide reaches the GLP-1 receptors on your pancreatic cells, it kicks off a cascade of signals inside those cells. The receptor activates a messenger molecule called cAMP, which ramps up the machinery that produces and releases insulin. Critically, this insulin release is glucose-dependent, meaning it only happens when your blood sugar is actually elevated. If your blood sugar is normal or low, the drug doesn’t force extra insulin out. This is a major safety advantage over older diabetes medications that could push blood sugar dangerously low.
Semaglutide also suppresses glucagon, a hormone that works opposite to insulin. Glucagon tells your liver to release stored sugar into your bloodstream. By dialing glucagon down after meals (when you don’t need that extra sugar), semaglutide reduces both fasting blood sugar levels and the spikes that happen after eating. It also suppresses a process in your liver called gluconeogenesis, where the liver manufactures new glucose from non-sugar sources. Together, these effects attack high blood sugar from multiple angles.
Beyond short-term blood sugar control, GLP-1 receptor activation supports the survival and function of the insulin-producing beta cells in your pancreas. In type 2 diabetes, these cells gradually burn out over time. Semaglutide activates a cellular survival pathway that helps protect them from that decline.
Why It Slows Your Digestion
One of semaglutide’s most noticeable effects is how much it slows the movement of food through your stomach. In a study of women with obesity, semaglutide significantly delayed gastric emptying compared to placebo. Four hours after eating a solid meal, participants on semaglutide still had 37% of the meal sitting in their stomach, while the placebo group had none left. The time it took for half the meal to leave the stomach was 171 minutes on semaglutide versus 118 minutes on placebo.
This slower emptying does two things. First, it blunts the blood sugar spike that normally follows a meal, because glucose trickles into your bloodstream more gradually instead of flooding in all at once. Second, it keeps your stomach fuller for longer, which sends sustained “I’m not hungry” signals to your brain. Many people on Ozempic describe a dramatic reduction in appetite and food noise, that persistent background chatter about what to eat next. This is also why nausea is the most commonly reported side effect, especially when starting the medication or increasing the dose. Your stomach simply isn’t emptying as fast as your body expects.
How It Affects Your Brain
GLP-1 receptors aren’t just in your pancreas and gut. They’re also in areas of the brain that regulate appetite, reward, and satiety. Semaglutide crosses into the brain and acts on these receptors directly, reducing hunger signals and changing how rewarding high-calorie foods feel. People on the medication frequently report that cravings for rich or sugary foods simply quiet down, not through willpower but through a genuine shift in how appealing those foods seem.
This brain effect is separate from the stomach-slowing mechanism and likely accounts for a significant portion of the weight loss seen with the drug. It’s not just that you feel physically full sooner. Your drive to eat and your interest in food genuinely decrease.
What It’s Approved to Treat
Ozempic (the brand name for injectable semaglutide at diabetes doses) is approved for type 2 diabetes management and to reduce cardiovascular risk in people with type 2 diabetes and established heart disease. A higher-dose version of the same drug, sold as Wegovy, is approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition.
In 2024, the FDA approved Wegovy specifically to reduce the risk of heart attack, stroke, and cardiovascular death in adults with heart disease and obesity or overweight. That approval came from a trial of over 17,600 participants, which found that major cardiovascular events occurred in 6.5% of those taking semaglutide compared to 8% on placebo. That 1.5 percentage point difference translates to roughly a 20% relative reduction in risk, a meaningful benefit that extends the drug’s value well beyond blood sugar or weight.
Common Side Effects and Why They Happen
Most side effects trace directly back to how the drug works. Nausea, vomiting, diarrhea, and constipation are the most frequently reported issues, and they’re largely a consequence of slowed gastric emptying. Your digestive system is adjusting to a new pace. These effects tend to be worst during the dose escalation period, when you’re gradually increasing from a low starting dose to your target dose over several weeks. For most people, they improve with time as the body adapts.
Eating smaller meals, avoiding high-fat foods, and eating slowly can help manage the nausea. The gradual dose increases built into the prescribing schedule exist specifically to minimize these effects, giving your gut time to adjust before the dose goes up again.
Less common but more serious concerns include inflammation of the pancreas (pancreatitis) and gallbladder problems, both of which have been associated with GLP-1 receptor agonists as a class. Rapid weight loss from any cause can increase gallstone risk, and the significant weight loss semaglutide produces may contribute to this.
How the Weekly Injection Works in Practice
Ozempic is injected once a week, on the same day each week, using a prefilled pen with a small needle that goes just under the skin of the abdomen, thigh, or upper arm. Most people start at a low dose and increase every four weeks. Because the drug has such a long half-life, the timing doesn’t need to be exact, though consistency helps maintain steady drug levels. If you miss a dose by a day or two, you can still take it. If more than five days have passed, you skip that dose and wait for your next scheduled one.
The long circulation time also means that when you stop taking the medication, its effects don’t vanish overnight. Semaglutide lingers in your system for about five weeks after your last injection, so appetite and blood sugar effects taper gradually rather than snapping back immediately.